News & Events

• August 28, 2020
  

  Remote Digital Monitoring for Medical Product Development

• August 25, 2020
  

  Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions

  C-Path’s Crohn’s Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its first publication in the journal Inflammatory Bowel Diseases titled, “Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions.” The result of collaboration among experts in Crohn’s disease, including academia, health care institutes, foundations, public advocacy groups, industry and regulatory bodies, this work has identified biomarkers that can be used as drug development tools to advance clinical trials in IBD and potentially improve patient care.

  Free access: https://academic.oup.com/ibdjournal/advance-article/doi/10.1093/ibd/izaa215/5896885?guestAccessKey=70d1e3c0-2aaf-4d65-b1bb-292f7df3b625

• August 14, 2020
  

  ePRO Consortium Announces Publication of Open Access Article

• August 11, 2020
  

  Neonatal Adverse Events Severity Scale on NIH website

• August 11, 2020
  

  Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019